Does CBD Have Antiseptic Properties?

Could CBD be useful in the fight versus resistant bacterial strains? The arise from the University of Queensland in Australia recommend that it is possible. But before examining the research study in depth, it is useful to understand the evolution of the relationship in between germs and prescription antibiotics.

Considering that the revolutionary discovery of penicillin by Alexander Fleming in 1928, prescription antibiotics have been a vital tool in the fight versus germs and infections. And although we still use the same proven techniques today, germs have progressed. When exposed to prescription antibiotics, certain germs, fungis and parasites are able to adjust and cancel the effectiveness of the drug by developing resistance.

It’s worth mentioning that antimicrobial resistance was most likely to take place anyway, as the genetic code for germs changes in time. Nevertheless, it is thought that the overuse of prescription antibiotics is an important factor that speeds up the advancement of resistant strains.

According to the World Health Organization, antimicrobial resistance “is a progressively severe danger to international public health that needs action in all sectors of federal government and in society.” This has led scientists to think outside package by trying to recognize compounds that could be beneficial in the fight versus damaging germs. One of these compounds is cannabidiol (CBD), a cannabinoid found in Cannabis sativa.

Researchers are trying to find brand-new methods to attack infections and resistant germs.

Dr. Mark Blaskovich, Principal Investigator and Program Coordinator for the Community for Open Antimicrobial Drug Discovery and Senior Research Officer at the Institute for Molecular Bioscience at the University of Queensland, concluded that CBD works versus Gram-positive germs. Stress of Gram-positive germs consist of Staphylococcus aureus (common in skin infections) and Streptococcus pneumoniae (common in bacterial pneumonia).

Dr. Blaskovich provided his findings at a yearly conference of the American Society for Microbiology. In vitro samples of both types of gram-positive germs were treated with artificial CBD. The results led Dr. Blaskovich to the conclusion that CBD works at levels similar to those of prescription antibiotics vancomycin and daptomycin. He also discovered that CBD appeared to work against gram-positive strains of resistant germs, which numerous conventional prescription antibiotics are beginning to stop working.

” In specific, the activity was chosen versus the resistant strains of Staphylococcus aureus (MRSA, VISA, SARV), Streptococcus pneumoniae (MDR), and Enterococcus faecalis (ERV). Cannabidiol was bactericidal, had a low propensity to induce resistance and was active versus MRSA biofilms. “

The team also conducted another research study using topical CBD to treat a skin infection in mice. Again, although the results were positive, CBD did not appear to remove the infection, however just to reduce the number of bacterial cells.

Could CBD end up being an antibiotic?

While it is easy to hail this work as a significant breakthrough in the antibacterial capabilities of CBD, it is prematurely to quit on penicillin.

Although it is thought that the effectiveness of lake shore CBD might originate from the method it attacks the biofilm surrounding bacterial cells, the authors are still not sure of the system of action of CBD. They also did not hesitate to mention the drawbacks of the research study. Dr. Blaskovich explained that given that the results are in the preliminary stages, it is far too early for people to begin treating their CBD infections themselves.

The research study was also conducted in vitro (outside the human body), and there is a risk that the results of medical trials will not be the same. Numerous compounds have shown antibacterial efficacy in petri meals, however then failed at this important phase. It ought to also be discussed that the two research studies were carried out in collaboration with Botanix Pharmaceuticals Ltd, a pharmaceutical company concentrating on topical eureka CBD products.

Nevertheless, this research study could be an important step forward for CBD and the fight versus antimicrobial resistance. CBD continues to have an excellent security profile and is ruled out toxic even in large amounts. Thankfully, Dr. Blaskovich and his team strategy to continue their research study.

Scroll to top